cAMP promotes growth arrest and/or apoptosis of various types of lymphoma, particularly CLL, and PDE7 inhibitors can increase cAMP concentration and kill CLL cells20,21, which is suggesting that PDE7B may act as a therapeutic target in CLL. Here, PDE7B is linked to lymphoma.